Estados financieros detallados de Celldex Therapeutics, Inc. (CLDX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Celldex Therapeutics, Inc. registró ingresos de $1.5M en el último ejercicio fiscal, con un CAGR de 5 años del -27.4%.
Márgenes de los últimos 12 meses: margen bruto -568.5%, margen operativo -2909.5%, margen neto -2683.9%.
Al precio actual de $38.71, CLDX presenta beneficios negativos (P/E no significativo) y un ROE del -52.36%. La capitalización bursátil es de $2.6B.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $6.8M | $12.7M | $9.5M | $3.6M | $7.4M | $4.7M | $2.4M | $6.9M | $7.0M | $1.5M |
| Coste de Ventas | $102.0M | $96.2M | $66.4M | $42.7M | $42.5M | $53.3M | $82.3M | $118.0M | $163.6M | 0 |
| Beneficio Bruto | -$95.2M | -$83.4M | -$56.9M | -$39.1M | -$35.1M | -$48.7M | -$79.9M | -$111.1M | -$156.5M | $1.5M |
| I+D | $102.7M | $96.2M | $66.4M | $42.7M | $40.5M | $56.8M | $82.3M | $118.0M | $163.6M | $245.1M |
| Generales y Administrativos | $36.0M | $25.0M | $19.3M | $15.4M | $14.5M | $20.5M | $27.2M | $30.9M | $38.5M | $43.8M |
| Gastos Operativos | $37.7M | $38.1M | $99.5M | $15.9M | $28.2M | $22.6M | $35.3M | $43.4M | $38.5M | $288.9M |
| Beneficio Operativo | -$132.9M | -$121.5M | -$156.4M | -$55.0M | -$63.4M | -$71.2M | -$115.2M | -$154.5M | -$195.1M | -$287.4M |
| EBITDA | -$124.4M | -$104.0M | -$72.6M | -$49.7M | -$45.6M | -$66.1M | -$104.2M | -$139.0M | -$154.7M | -$255.4M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$128.5M | -$117.3M | -$151.9M | -$50.9M | -$60.9M | -$70.7M | -$112.3M | -$141.4M | -$157.9M | -$258.8M |
| Impuestos | 0 | -$24.3M | -$765000 | 0 | -$1.2M | -$226999 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$128.5M | -$93.0M | -$151.2M | -$50.9M | -$59.8M | -$70.5M | -$112.3M | -$141.4M | -$157.9M | -$258.8M |
| BPA | $-18.99 | $-10.86 | $-14.48 | $-3.51 | $-2.02 | $-1.64 | $-2.40 | $-2.92 | $-2.45 | $-3.90 |
| BPA Diluido | $-18.99 | $-10.86 | $-14.48 | $-3.51 | $-2.02 | $-1.64 | $-2.40 | $-2.92 | $-2.45 | $-3.90 |
| Acciones en Circulación (Diluidas) | $6.8M | $8.6M | $10.4M | $14.5M | $29.6M | $42.9M | $46.9M | $48.4M | $64.4M | $66.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | $75000 | $15000 | $22000 |
| Beneficio Bruto | -$62.9M | $75000 | -$839000 | $22000 |
| Beneficio Operativo | -$73.6M | -$87.2M | -$84.4M | -$80.6M |
| EBITDA | -$66.2M | -$80.5M | -$77.8M | -$72.6M |
| Beneficio Neto | -$67.0M | -$81.4M | -$78.7M | -$73.5M |
| BPA | $-1.01 | $-1.23 | $-1.18 | $-0.94 |
| BPA Diluido | $-1.01 | $-1.23 | $-1.18 | $-0.94 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $42.5M | $40.3M | $24.3M | $11.2M | $43.8M | $39.1M | $29.4M | $34.8M | $28.4M | $28.9M |
| Inversiones a Corto | $147.3M | $99.1M | $69.7M | $53.0M | $150.6M | $369.1M | $275.5M | $386.9M | $696.9M | $489.7M |
| Cuentas por Cobrar | $1.8M | $1.9M | $3.2M | $1.2M | $1.8M | $172000 | $347000 | $4.5M | $700000 | $2.0M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $195.6M | $144.8M | $99.1M | $66.7M | $197.8M | $410.8M | $317.7M | $431.7M | $747.2M | $534.7M |
| Inmovilizado Material | $13.2M | $10.4M | $6.1M | $7.5M | $7.3M | $6.5M | $7.7M | $6.6M | $8.2M | $7.8M |
| Fondo de Comercio | $91.0M | $91.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $81.5M | $67.6M | $50.6M | $48.7M | $30.7M | $27.2M | $27.2M | $27.2M | $27.2M | $27.2M |
| Activos Totales | $383.4M | $315.6M | $155.8M | $122.9M | $235.8M | $444.7M | $352.7M | $465.6M | $792.3M | $583.0M |
| Cuentas por Pagar | $1.7M | $1.7M | $1.1M | $1.2M | $1.0M | $1.2M | $3.3M | $3.5M | $3.3M | $1.2M |
| Deuda a Corto | 0 | $6.6M | $4.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $35.2M | $27.7M | $12.6M | $11.6M | $14.2M | $16.5M | $18.6M | $31.1M | $39.5M | $51.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $117.9M | $79.3M | $31.7M | $28.9M | $26.5M | $25.2M | $26.5M | $36.5M | $45.3M | $55.8M |
| Reservas | -$719.5M | -$812.5M | -$962.4M | -$1.01B | -$1.07B | -$1.14B | -$1.26B | -$1.40B | -$1.56B | -$1.81B |
| Patrimonio Neto | $265.4M | $236.4M | $124.1M | $94.0M | $209.4M | $419.5M | $326.2M | $429.2M | $747.0M | $527.2M |
| Deuda Total | 0 | $6.6M | $4.5M | $3.7M | $3.5M | $3.0M | $4.0M | $2.5M | $3.8M | $2.3M |
| Deuda Neta | -$189.8M | -$132.9M | -$89.5M | -$60.5M | -$190.9M | -$405.2M | -$300.9M | -$419.2M | -$721.5M | -$516.2M |
| Capital Circulante | $160.3M | $117.0M | $86.5M | $55.1M | $183.6M | $394.3M | $299.1M | $400.6M | $707.7M | $483.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $36.0M | $28.9M | $35.7M | $47.5M |
| Activos Totales | $648.4M | $583.0M | $511.3M | $782.3M |
| Pasivos Totales | $50.1M | $55.8M | $55.0M | $67.8M |
| Patrimonio Neto | $598.4M | $527.2M | $456.2M | $714.6M |
| Deuda Total | $2.6M | $2.3M | $1.9M | $4.9M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$128.5M | -$93.0M | -$151.2M | -$50.9M | -$59.8M | -$70.5M | -$112.3M | -$141.4M | -$157.9M | -$258.8M |
| Amortizaciones | $4.1M | $5.3M | $3.8M | $4.9M | $3.9M | $3.1M | $1.4M | $3.0M | $3.2M | -$2.5M |
| Compensación en Acciones | $15.3M | $12.3M | $8.1M | $4.6M | $3.9M | $9.0M | 0 | $23.9M | $34.2M | $36.2M |
| Cambio en Capital Circulante | -$6.6M | -$12.2M | -$15.4M | -$4.3M | -$299000 | -$1.1M | -$3.9M | $13.5M | -$21.6M | $14.1M |
| Flujo de Caja Operativo | -$113.0M | -$99.9M | -$75.2M | -$46.4M | -$40.4M | -$60.9M | -$103.7M | -$107.3M | -$157.8M | -$210.9M |
| Inversiones (CapEx) | -$2.8M | -$1.8M | -$813000 | -$731000 | -$1.6M | -$1.2M | -$1.8M | -$1.8M | -$1.9M | -$2.7M |
| Adquisiciones | $4.6M | $1.8M | $342000 | $20000 | $55000 | $27000 | $69000 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$115.8M | -$101.7M | -$76.0M | -$47.1M | -$42.0M | -$62.2M | -$105.6M | -$109.1M | -$159.7M | -$213.7M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$48.6M | -$63.9M | -$65.6M | -$57.4M |
| Inversiones (CapEx) | -$440000 | -$993000 | -$1.6M | -$3.2M |
| Flujo de Caja Libre | -$49.1M | -$64.9M | -$67.2M | -$60.6M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $8.8M | $8.9M | $8.5M | $8.4M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +87.8% | -25.2% | -62.5% | +107.6% | -37.3% | -49.3% | +192.0% | +2.0% | -78.6% |
| Crecimiento Beneficio Neto (anual) | | +27.6% | -62.5% | +66.3% | -17.5% | -18.0% | -59.3% | -25.9% | -11.6% | -63.9% |
| Crecimiento BPA (anual) | | +42.8% | -33.3% | +75.8% | +42.5% | +18.8% | -46.3% | -21.7% | +16.1% | -59.2% |
| Cambio en Acciones (anual) | | +26.6% | +21.8% | +38.9% | +104.3% | +44.6% | +9.4% | +3.3% | +32.9% | +3.3% |
| Crecimiento FCF (anual) | | +12.1% | +25.2% | +38.0% | +11.0% | -48.2% | -69.8% | -3.4% | -46.4% | -33.8% |
| Margen Bruto | -1403.5% | -654.7% | -596.7% | -1094.3% | -473.4% | -1046.2% | -3389.9% | -1614.5% | -2229.8% | 100.0% |
| Margen Operativo | -1958.7% | -953.7% | -1640.1% | -1540.2% | -854.1% | -1531.8% | -4889.0% | -2245.3% | -2778.9% | -19160.0% |
| Margen EBITDA | -1833.7% | -816.3% | -761.2% | -1390.1% | -615.3% | -1420.8% | -4420.9% | -2020.0% | -2203.5% | -17028.0% |
| Margen Neto | -1894.0% | -730.1% | -1585.1% | -1424.0% | -805.9% | -1516.0% | -4765.6% | -2054.8% | -2248.8% | -17253.3% |
| Margen FCF | -1706.3% | -798.2% | -797.3% | -1319.5% | -565.6% | -1336.4% | -4478.6% | -1585.2% | -2274.9% | -14243.9% |
| Tasa Impositiva Efectiva | -0.0% | 20.7% | 0.5% | -0.0% | 1.9% | 0.3% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-17.11 | $-11.87 | $-7.28 | $-3.25 | $-1.42 | $-1.45 | $-2.25 | $-2.25 | $-2.48 | $-3.21 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $6.8M | $8.6M | $10.4M | $14.5M | $29.6M | $42.9M | $46.9M | $48.4M | $64.4M | $66.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -52.36% |
| Rentabilidad sobre capital invertido | -45.10% |
| Rentabilidad sobre activos | -38.42% |
| Margen bruto | -56850.89% |
| Margen operativo | -290948.21% |
| Margen neto | -268385.71% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 11.82 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 14.43 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -2.80 | -3.92 | -0.21 | -0.64 | -8.67 | -23.56 | -18.57 | -13.58 | -10.31 | -6.96 |
| P/VC | 1.35 | 1.54 | 0.25 | 0.34 | 2.48 | 3.95 | 6.41 | 4.48 | 2.18 | 3.43 |
| P/V | 52.96 | 28.65 | 3.28 | 9.05 | 70.00 | 356.16 | 886.63 | 279.16 | 231.80 | 1204.09 |
| Margen Bruto | -1403.5% | -654.7% | -596.7% | -1094.3% | -473.4% | -1046.2% | -3389.9% | -1614.5% | -2229.8% | 100.0% |
| Margen Operativo | -1958.7% | -953.7% | -1640.1% | -1540.2% | -854.1% | -1531.8% | -4889.0% | -2245.3% | -2778.9% | -19160.0% |
| Margen Neto | -1894.0% | -730.1% | -1585.1% | -1424.0% | -805.9% | -1516.0% | -4765.6% | -2054.8% | -2248.8% | -17253.3% |